<DOC>
	<DOCNO>NCT01435655</DOCNO>
	<brief_summary>Tafamidis develop oral specific stabilizer transthyretin tetramer .</brief_summary>
	<brief_title>The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Amyloid Neuropathies</mesh_term>
	<mesh_term>Amyloid Neuropathies , Familial</mesh_term>
	<criteria>Transthyretin amyloid polyneuropathy V30M nonV30M transthyretin mutation . Subject amyloid document biopsy accordance institutional site standard care . Primary amyloidosis secondary amyloidosis . History liver transplant .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>